Cargando…

Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis

Objective: Studies have shown that oxidative stress (OS) is related to the pathophysiology of schizophrenia (SCZ), but whether antipsychotics can induce OS has not been investigated well. Moreover, antipsychotics have differential effects on the OS level modulation, i.e., different types of antipsyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mi, Wang, Chunzhi, Zhao, Guocheng, Kong, Di, Liu, Liju, Yuan, Shuai, Chen, Wei, Feng, Can, Li, Zezhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2023
Materias:	Neurology, Pharmacology, Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190148/ https://www.ncbi.nlm.nih.gov/pubmed/35794775 http://dx.doi.org/10.2174/1570159X20666220706101021

Ejemplares similares

Dynamic functional thalamocortical dysconnectivity in schizophrenia correlates to antipsychotics response
por: Yang, Mi, et al.
Publicado: (2023)

Sex differences in factors influencing hospital-acquired pneumonia in schizophrenia patients receiving modified electroconvulsive therapy
por: Yang, Mi, et al.
Publicado: (2023)

Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis
por: Shi, Xiao-Jie, et al.
Publicado: (2021)

Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002)

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects
por: Ackenheil, Manfred, et al.
Publicado: (2004)

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Non-antipsychotic medicines and modified electroconvulsive therapy are risk factors for hospital-acquired pneumonia in schizophrenia patients
por: Yang, Yan, et al.
Publicado: (2023)

Sex-based influential factors for dental caries in patients with schizophrenia
por: Yang, Mi, et al.
Publicado: (2023)

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
por: Pandey, Manisha, et al.
Publicado: (2022)

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
por: Tsuda, Yoshiyuki, et al.
Publicado: (2014)

Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
por: Bhatta, Madhav P., et al.
Publicado: (2021)

Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting
por: Farr, Amanda M., et al.
Publicado: (2014)

Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers
por: Wang, Shuying, et al.
Publicado: (2023)

Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review
por: Gardea-Resendez, Manuel, et al.
Publicado: (2020)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials
por: Palermo, Sara, et al.
Publicado: (2019)

Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis
por: Ilzarbe, Lidia, et al.
Publicado: (2023)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Ren, Xinhua S, et al.
Publicado: (2009)

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia
por: Fares, Jaballah, et al.
Publicado: (2023)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Treatment Effect of Long-Term Antipsychotics on Default-Mode Network Dysfunction in Drug-Naïve Patients With First-Episode Schizophrenia: A Longitudinal Study
por: Deng, Mengjie, et al.
Publicado: (2022)

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022)

Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database
por: Guo, Kangyuan, et al.
Publicado: (2022)

Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond
por: Waddington, John L., et al.
Publicado: (2020)

Associations between antipsychotics and the risk of incident cardiovascular diseases in individuals with schizophrenia: a nested case–control study
por: Peng, Peng, et al.
Publicado: (2023)

Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial
por: Tang, Yiguo, et al.
Publicado: (2023)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
por: Machado-Duque, Manuel Enrique, et al.
Publicado: (2021)

Sevoflurane Ameliorates Schizophrenia in a Mouse Model and Patients: A Pre-Clinical and Clinical Feasibility Study
por: Zhao, Tianyun, et al.
Publicado: (2022)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
por: García-Ruiz, Antonio J, et al.
Publicado: (2012)

A Functional Neuroimaging Meta-Analysis of Self-Related Processing in Schizophrenia
por: Potvin, Stéphane, et al.
Publicado: (2019)

Telomere Length: A Potential Biomarker for the Risk and Prognosis of Stroke
por: Tian, Yanjun, et al.
Publicado: (2019)

Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
por: Jiao, Shimeng, et al.
Publicado: (2022)

Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review
por: Saber, Wael K, et al.
Publicado: (2022)

Delayed Presentation of Antipsychotic Withdrawal Tardive Dyskinesia: A Case Report
por: Solanki, Siddhant, et al.
Publicado: (2023)

Editorial: Antipsychotics of New Generation: Where Are We now?
por: Lipina, Tatiana V., et al.
Publicado: (2021)

Cigarette Smoking and Risk of Different Pathologic Types of Stroke: A Systematic Review and Dose-Response Meta-Analysis
por: Luo, Jianyu, et al.
Publicado: (2022)

Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2018)

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China
por: Luo, Rui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1bcpricu50m94l5tocs472sktb